StockData
XTL Biopharmaceuticals Ltd logo

XTL Biopharmaceuticals Ltd (XTLB) dividend history

XTLBNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 30, 2026Score 0/30
$1.60−0.04 (-2.44%)

Close on Nov 13, 2026Market cap $15.14MP/E –Yield –

Dividends

XTL Biopharmaceuticals has not reported a dividend

No dividend per share appears in XTL Biopharmaceuticals's annual filings since fiscal 2014.

See a number that looks wrong?